XML 68 R49.htm IDEA: XBRL DOCUMENT v3.23.2
Business Segments - Schedule of Information on Company's Business Segments (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Segment Reporting Information [Line Items]          
Net sales $ 846.2 $ 796.1 $ 1,691.6 $ 1,547.2  
ADJUSTED EBITDA 240.7 219.2 470.5 433.9  
Interest expense 13.3 9.5 26.4 19.0  
Depreciation 14.4 12.5 27.2 24.7  
Amortization 23.2 16.9 46.8 32.2  
Fair value inventory step-up charges 0.0 0.4 0.0 0.4  
Restructuring expenses and asset impairments 3.6 2.8 4.1 2.8  
Gains on sales of asset 0.0 0.0 0.0 (2.7)  
Credit loss on note receivable from collaborative partner 7.7 0.0 7.7 0.0  
Income before income taxes 178.5 177.1 358.3 357.5  
Total assets 5,719.9   5,719.9   $ 5,511.9
Intersegment eliminations          
Segment Reporting Information [Line Items]          
Net sales (3.2) (1.0) (5.0) (1.8)  
Operating segments          
Segment Reporting Information [Line Items]          
ADJUSTED EBITDA 262.3 243.7 518.9 476.3  
Corporate and other          
Segment Reporting Information [Line Items]          
ADJUSTED EBITDA (21.6) (24.5) (48.4) (42.4)  
Total assets 153.2   153.2   132.1
Fluid & Metering Technologies          
Segment Reporting Information [Line Items]          
Net sales 324.1 299.5 645.2 571.4  
ADJUSTED EBITDA 114.1 95.0 220.3 183.4  
Income before income taxes 178.5 177.1 358.3 357.5  
Total assets 1,698.3   1,698.3   1,676.9
Fluid & Metering Technologies | Intersegment eliminations          
Segment Reporting Information [Line Items]          
Net sales 1.0 0.4 1.7 0.5  
Fluid & Metering Technologies | Operating segments          
Segment Reporting Information [Line Items]          
Net sales 325.1 299.9 646.9 571.9  
Health & Science Technologies          
Segment Reporting Information [Line Items]          
Net sales 338.4 325.4 688.7 640.0  
ADJUSTED EBITDA 93.7 103.6 194.4 203.4  
Total assets 3,075.4   3,075.4   2,931.1
Health & Science Technologies | Intersegment eliminations          
Segment Reporting Information [Line Items]          
Net sales 1.1 0.6 1.8 1.2  
Health & Science Technologies | Operating segments          
Segment Reporting Information [Line Items]          
Net sales 339.5 326.0 690.5 641.2  
Fire & Safety/Diversified Products          
Segment Reporting Information [Line Items]          
Net sales 183.7 171.2 357.7 335.8  
ADJUSTED EBITDA 54.5 45.1 104.2 89.5  
Total assets 793.0   793.0   $ 771.8
Fire & Safety/Diversified Products | Intersegment eliminations          
Segment Reporting Information [Line Items]          
Net sales 1.1 0.0 1.5 0.1  
Fire & Safety/Diversified Products | Operating segments          
Segment Reporting Information [Line Items]          
Net sales $ 184.8 $ 171.2 $ 359.2 $ 335.9